Registry for monitoring heart conditions
Official title: The Multicenter Cardiology Monitoring Platform Registry (mCMP-registry)
Run by Maastricht University Medical Center · NCT04976348 · Data updated 2026-11-12
This study is collecting health information from people with heart symptoms to see if it can help doctors catch heart problems earlier and understand them better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 40000 (estimated) |
| Sponsor | Maastricht University Medical Center Academic / other |
| Locations | 1 site (Maastricht, Limburg) |
| Status | Recruiting |
| Started | July 1, 2021 |
| Main results expected | December 2051 |
| Study ends | December 2051 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT04976348 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals aged 16 and older who have been referred for cardiac symptoms or screening.
✕Probably not a fit
Patients who are unwilling to participate or unable to provide informed consent may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The multicenter Cardiology Monitoring Platform registry (mCMP-registry) is a prospective observational registry that collects multi-omics diagnostic measurements as part of routine clinical care. It aims to optimize early diagnosis and risk stratification of cardiovascular diseases, particularly focusing on cardiomyopathy phenotypes, arrhythmias, and coronary artery disease. Participants, aged 16 and older, are referred to cardiology or genetics departments for cardiac symptoms or screening. The registry also includes optional bio-banking and yearly questionnaires to enhance understanding of underlying pathophysiological processes.
Why it matters
Potential benefit: If successful, this registry could lead to improved early diagnosis and management of cardiovascular diseases, ultimately enhancing patient outcomes.
How similar studies have gone: Other observational registries focusing on cardiovascular diseases have shown success in improving diagnosis and treatment strategies, indicating potential for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Referred to the cardiology or genetic department for heart failure like symptoms (as stated in the ESC 2016 Guidelines(3)) or for cardiac/cardiogenetic screening; * Age ≥16 years. Exclusion Criteria: * Unwillingness to participate or unable to give written informed consent (e.g. due to language barriers or severe intellectual disability).
Where it's running
-
Maastricht UMC+
Maastricht, Limburg, Netherlands Recruiting
Study contacts
- Principal investigator: Hans-Peter Brunner-La Rocca, Prof. — Maastricht University Medical Center
- Study coordinator: Jerremy Weerts, MD
- Email: jerremy.weerts@mumc.nl
- Phone: + 31 43 3871592
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RHYthm and Myocardial Function Relationship in Heart Disease
This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.
-
Study of heart conditions using advanced imaging techniques
This study is trying to find out what causes different heart conditions in Hispanic and African American people in the Bronx by using advanced imaging techniques.
-
Stereotactic body radiation therapy versus catheter ablation for ventricular tachycardia in structural heart disease
This trial will test whether a focused radiation treatment (SBRT) can reduce ventricular tachycardia episodes more than standard catheter ablation in people with advanced structural heart disease.
-
Evaluating different approaches to cardiac pacing in patients
This study is testing different ways to place pacemakers in adults to see which methods work best and are safest for patients needing heart support.
-
Colchicine treatment for chronic inflammatory cardiomyopathy
This study tests if colchicine can help people with chronic inflammatory cardiomyopathy who have heart issues feel better by reducing inflammation in their hearts.
-
Understanding how heart conditions affect tolerance to rapid heart rates
This study is testing how well people with heart conditions, especially those with coronary artery disease, can handle fast heart rates and whether treating their condition with stents can help them tolerate it better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.